Add BrightSurf on Google Email

Livestock disease risk tied to herd management style

A new study reveals that livestock managed in a system where they are the sole source of an owner's livelihood are more likely to become infected with PPRV. Herds from pastoral villages had 3.8 times the risk of becoming infected compared to agropastoral villages.

SourcePenn State·JournalEpidemiology and Infection·DateSep 4, 2019

How chikungunya virus may cause chronic joint pain

Researchers developed a reporter system to permanently mark cells infected with chikungunya virus, revealing that marked cells containing most of the persistent RNA can survive for at least 112 days. Treatment with an antibody reduces the number of marked cells in muscle and skin.

SourcePLOS·JournalPLOS Pathogens·DateAug 29, 2019

Cell-free DNA detects pathogens and quantifies damage

A new assay uses cell-free DNA to identify viruses and bacteria in the human body while also quantifying injuries to organs. This test is simple, fast, low-cost, and generalizable enough to identify thousands of pathogens, making it a major step towards personalizing therapy and making organ transplantation safer.

SourceCornell University·JournalProceedings of the National Academy of Sciences·DateAug 29, 2019

Birth defects associated with Zika virus infection may depend on mother's immune response

New research suggests that the risk of developing microcephaly due to Zika virus infection depends on the types of antibodies produced by pregnant mothers. Antibodies from mothers of babies with microcephaly are more effective at neutralizing the virus, but also show enhanced ability to boost viral entry into human cells.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateAug 14, 2019

CSU team uncovers potential for Rift Valley fever virus transmission in Colorado livestock

A team at Colorado State University discovered that Culex tarsalis mosquitoes, a primary vector for West Nile virus, can transmit Rift Valley fever virus to livestock and humans in Colorado. The researchers found that these mosquitoes feed on both humans and livestock, making them a significant threat for potential outbreak.

SourceColorado State University·JournalTransboundary and Emerging Diseases·DateAug 12, 2019

Lassa virus' soft spot revealed

Researchers at La Jolla Institute for Immunology identified the molecular properties of antibodies that neutralize Lassa virus. By understanding these properties, they can create a map for rational vaccine design, aiming to develop effective treatments or vaccines against this deadly disease.

Trapping female mosquitoes helps curb chikungunya virus

Researchers found that CDC-developed Autocidal Gravid Ovitrap (AGO) traps successfully protected people from chikungunya virus infection in Puerto Rican communities. The study showed a significant reduction in CHIKV seropositivity among participants in intervention areas with AGO traps compared to those without traps.

SourcePLOS·JournalPLOS Neglected Tropical Diseases·DateJul 25, 2019

Plant viruses may be reshaping our world

Recent advances suggest that plant viruses are not just disease-causing entities, but can also play a significant role in the functioning of diverse ecosystems. Viruses have been found to be present in humans, with around 100,000 pieces of viral DNA elements making up 8% of our genome.

SourceArizona State University·JournalNature Reviews Microbiology·DateJul 17, 2019

Honeybee mite raises bumblebee virus risk

A study by the University of Exeter found that Varroa destructor mites indirectly increase infection rates among wild bumblebees by spreading deformed wing virus (DWV) through honeybee colonies. This highlights the need for beekeepers to treat their affected colonies.

SourceUniversity of Exeter·JournalEcology Letters·DateJun 12, 2019

Checkmate for hepatitis B viruses in the liver

Researchers at Helmholtz Zentrum München have developed a novel T-cell therapy that can eliminate hepatitis B viruses from the liver, paving the way for a potential cure. The therapy involves genetically modifying patient-specific T cells to recognize and attack infected liver cells, with promising results in a mouse model.